


Kairos Discovery
Biotechnology Research • Lyon, Auvergne-Rhône-Alpes, France • 1-10 Employees
Company overview
| Headquarters | 28, Rue Laennec, Lyon, Auvergne-Rhône-Alpes 69008, FR |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Pharma, Drug Discovery, Oncology, Medicinal Chemistry, Kinase Inhibitor |
| Founded | 2022 |
| Employees | 1-10 |
| Socials |
Key Contacts at Kairos Discovery
Alexandre Bancet
Chief Executive Officer
Isabelle Krimm
Co-Founder Of Kairos Discovery
David Neves
Chief Technology Officer
About Kairos Discovery
Founded in late 2022 based on academic research, Kairos Discovery is a biopharmaceutical company focused on developing innovative cancer therapies. Using drug discovery platform, the company's strategy centers on the identification and optimization of novel therapeutics targeting well-validated cancer pathways that currently lack approved targeted treatments.
Kairos Discovery revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,500,000 |
| Total funding | $1,300,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Kairos Discovery has 7 employees across 6 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



